A facile system for construction of HSV-1 variants: Site directed mutation of the UL26 protease gene in HSV-1

被引:13
|
作者
Register, RB [1 ]
Shafer, JA [1 ]
机构
[1] MERCK SHARP & DOHME LTD,DEPT BIOL CHEM,RES LABS,W POINT,PA 19486
关键词
herpes simplex virus-1 variants; HSV-1; protease; UL26; Pra;
D O I
10.1016/0166-0934(95)01984-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A 2-plasmid/4-cosmid-based system of mutagenesis is described for construction of herpes simplex virus type 1 (HSV-1) variants with point mutations in the protease gene. The system was used to reconstruct a mutant virus (V701) with Tyr30 to Phe and Ala48 to Val mutations in HSV-1 protease that exhibits the temperature sensitive phenotype of the previously characterized temperature sensitive HSV-1 mutant, ts1201. The 2-plasmid/4-cosmid system of mutagenesis was further validated by using it to construct a virus wherein the active site Ser129 of HSV-1 protease was mutated to Ala. The resulting virus mutant (V713) grew only on the Vero host range cell line PHS-23. In V713 infected Vero cells, the processing of Pra to N-o was almost completely blocked, and B capsids accumulated in the nucleus in crystal-like aggregates, suggesting that protease activity is required for emergence of monodispersed capsids from these aggregates. Back mutation of Ala129 to Ser using the V713 viral DNA as template for PCR mutagenesis restored the wild-type phenotype verifying that the replicative incompetence of V713 reflected only the effect of the Ser to Ala mutation. The 2-plasmid/4-cosmid system of mutagenesis (and modifications thereof) should facilitate production of new mutant viruses for delineating interactions of domains of HSV-1 protease (as well as other HSV-1 proteins) important for virus replication.
引用
收藏
页码:181 / 193
页数:13
相关论文
共 50 条
  • [41] A Mutation in the Herpes Simplex Virus Type 1 (HSV-1) UL29 Gene is Associated with Anti-Herpesvirus Drugs' Susceptibility
    Yamada, Souichi
    Harada, Shizuko
    Fujii, Hikaru
    Kinoshita, Hitomi
    Nguyen, Phu Hoang Anh
    Shibamura, Miho
    Yoshikawa, Tomoki
    Kawahara, Madoka
    Ebihara, Hideki
    Saijo, Masayuki
    Fukushi, Shuetsu
    VIRUSES-BASEL, 2024, 16 (12):
  • [42] THE SPREAD OF HSV-1 FROM THE SITE OF INFECTION TO THE CNS IN INBRED MICE
    KUMEL, O
    SCHRODER, CH
    KIRCHNER, H
    KAERNER, HC
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1982, 253 (01): : 26 - 26
  • [43] HSV-1 employs UL56 to antagonize expression and function of cGAMP channels
    Blest, Henry T. W.
    Redmond, Alexander
    Avissar, Jed
    Barker, Jake
    Bridgeman, Anne
    Fowler, Gerissa
    Chauveau, Lise
    Hertzog, Jonny
    Vendrell, Iolanda
    Fischer, Roman
    Iversen, Marie B.
    Jing, Lichen
    Koelle, David M.
    Paludan, Soren R.
    Kessler, Benedikt M.
    Crump, Colin M.
    Research, Jan Rehwinkel
    CELL REPORTS, 2024, 43 (05):
  • [46] The unique structure of HSV-1 UL21, a multifunctional tegument protein.
    Metrick, Claire M.
    Heldwein, Ekaterina E.
    PROTEIN SCIENCE, 2016, 25 : 158 - 158
  • [47] Improved purification protocol of the HSV-1 protease catalytic domain, using immunoaffinity
    McKercher, G
    Bonneau, PR
    Lagacé, L
    Thibeault, D
    Massariol, MJ
    Krogsrud, R
    Lawetz, C
    McDonald, PC
    Cordingley, MG
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1997, 75 (06): : 795 - 801
  • [48] Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector
    Herrlinger, U
    Kramm, CM
    Aboody-Guterman, KS
    Silver, JS
    Ikeda, K
    Johnston, KM
    Pechan, PA
    Barth, RF
    Finkelstein, D
    Chiocca, EA
    Louis, DN
    Breakefield, XO
    GENE THERAPY, 1998, 5 (06) : 809 - 819
  • [49] Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector
    U Herrlinger
    CM Kramm
    KS Aboody-Guterman
    JS Silver
    K Ikeda
    KM Johnston
    PA Pechan
    RF Barth
    D Finkelstein
    EA Chiocca
    DN Louis
    XO Breakefield
    Gene Therapy, 1998, 5 : 809 - 819
  • [50] THE NUCLEOTIDE-SEQUENCE OF THE GB GLYCOPROTEIN GENE OF HSV-2 AND COMPARISON WITH THE CORRESPONDING GENE OF HSV-1
    BZIK, DJ
    DEBROY, C
    FOX, BA
    PEDERSON, NE
    PERSON, S
    VIROLOGY, 1986, 155 (02) : 322 - 333